Related references
Note: Only part of the references are listed.Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial
Amita Patnaik et al.
CLINICAL CANCER RESEARCH (2021)
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
Navid Sobhani et al.
CELLS (2021)
The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells-A Systematic Analysis
Nina Schoenwaelder et al.
CANCERS (2021)
Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models
Christin Riess et al.
CELL DEATH DISCOVERY (2021)
Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies
Daniel Struder et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Anti-cancer therapy with cyclin-dependent kinase inhibitors: impact and challenges
Marika A. V. Reinius et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2021)
Molecular landscape of head and neck cancer and implications for therapy
Camile S. Farah
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study
Viktor Gruenwald et al.
ORAL ONCOLOGY (2020)
Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes
Hirotsugu Hino et al.
CANCER SCIENCE (2020)
Immune checkpoint signaling and cancer immunotherapy
Xing He et al.
CELL RESEARCH (2020)
CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck
Camelia Billard-Sandu et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2020)
Mechanisms of resistance to T cell-based immunotherapy in head and neck cancer
Maxwell Y. Lee et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)
Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib
Christin Riess et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells
Karina E. Gomez et al.
CANCER RESEARCH (2020)
Spheroids as a Type of Three-Dimensional Cell Cultures-Examples of Methods of Preparation and the Most Important Application
Kamila Bialkowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib
Melania Poratti et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
An Effective Primary Head and Neck Squamous Cell Carcinoma In Vitro Model
Felix Oppel et al.
CELLS (2019)
Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy
Madison Canning et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
Teodora Alexa-Stratulat et al.
DRUG RESISTANCE UPDATES (2019)
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019)
Concepcion Sanchez-Martinez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance
Jinfang Zhang et al.
NATURE (2018)
Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2-advanced breast cancer
Silvia Paola Corona et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Phase II multi-site investigation of neoadjuvant pembrolizumab and adjuvant concurrent radiation and pembrolizumab with or without cisplatin in resected head and neck squamous cell carcinoma.
Trisha Michel Wise-Draper et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma
Christina Karamboulas et al.
CELL REPORTS (2018)
Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection
Franziska Niehr et al.
CLINICAL CANCER RESEARCH (2018)
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers Insights From a Precision Oncology Sequencing Platform
Luc G. T. Morris et al.
JAMA ONCOLOGY (2017)
Deciphering molecular mechanisms of arginine deiminase-based therapy - Comparative response analysis in paired human primary and recurrent glioblastomas
Claudia Maletzki et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
Ge Zhou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
In Vitro Tumor Models: Advantages, Disadvantages, variables, and Selecting the Right Platform
Moriah E. Katt et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2016)
Establishment and characterization of cell lines from chromosomal instable colorectal cancer
Claudia Maletzki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience
D. Van Gestel et al.
BRITISH JOURNAL OF RADIOLOGY (2011)
Molecular biologic characteristics of seven new cell lines of squamous cell carcinomas of the head and neck and comparison to fresh tumor tissue
HJ Welkoborsky et al.
ONCOLOGY (2003)
Share Paper
